NO20013093D0 - Anvendelse av antistoffer for vaksinering mot kreft - Google Patents

Anvendelse av antistoffer for vaksinering mot kreft

Info

Publication number
NO20013093D0
NO20013093D0 NO20013093A NO20013093A NO20013093D0 NO 20013093 D0 NO20013093 D0 NO 20013093D0 NO 20013093 A NO20013093 A NO 20013093A NO 20013093 A NO20013093 A NO 20013093A NO 20013093 D0 NO20013093 D0 NO 20013093D0
Authority
NO
Norway
Prior art keywords
against cancer
antibodies
vaccination against
prophylactically
medicament
Prior art date
Application number
NO20013093A
Other languages
English (en)
Other versions
NO20013093L (no
NO329917B1 (no
Inventor
Helmut Eckert
Hans Loibner
Original Assignee
Igeneon Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Gmbh filed Critical Igeneon Gmbh
Publication of NO20013093D0 publication Critical patent/NO20013093D0/no
Publication of NO20013093L publication Critical patent/NO20013093L/no
Publication of NO329917B1 publication Critical patent/NO329917B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013093A 1999-01-13 2001-06-21 Anvendelse av antistoffer for fremstilling av et farmasoytisk preparat mot cancer som uttrykker Ep-CAM NO329917B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH5199 1999-01-13
PCT/EP2000/000174 WO2000041722A1 (de) 1999-01-13 2000-01-12 Verwendung von antikörpern zur vakzinierung gegen krebs

Publications (3)

Publication Number Publication Date
NO20013093D0 true NO20013093D0 (no) 2001-06-21
NO20013093L NO20013093L (no) 2001-09-10
NO329917B1 NO329917B1 (no) 2011-01-24

Family

ID=4178206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013093A NO329917B1 (no) 1999-01-13 2001-06-21 Anvendelse av antistoffer for fremstilling av et farmasoytisk preparat mot cancer som uttrykker Ep-CAM

Country Status (28)

Country Link
US (3) US7691372B2 (no)
EP (2) EP1140168B1 (no)
JP (1) JP4774551B2 (no)
KR (1) KR100771752B1 (no)
CN (1) CN1188169C (no)
AT (2) ATE219687T1 (no)
AU (1) AU768515B2 (no)
CA (1) CA2360382C (no)
CZ (1) CZ302801B6 (no)
DE (2) DE50009240D1 (no)
DK (2) DK1140168T3 (no)
EE (1) EE05474B1 (no)
ES (2) ES2177509T3 (no)
HK (1) HK1044487B (no)
HR (1) HRP20010526A2 (no)
HU (1) HU226150B1 (no)
ID (1) ID30223A (no)
IL (2) IL144265A0 (no)
IS (1) IS5998A (no)
MX (1) MXPA01007148A (no)
NO (1) NO329917B1 (no)
NZ (1) NZ512722A (no)
PL (1) PL201533B1 (no)
PT (2) PT1140168E (no)
SI (2) SI1230932T1 (no)
SK (1) SK286627B6 (no)
TR (1) TR200102034T2 (no)
WO (1) WO2000041722A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302801B6 (cs) * 1999-01-13 2011-11-16 Igeneon Krebs-Immuntherapie Forschungs Und Entwicklungs-Ag Použití protilátky namírené proti antigenu bunecné membrány Ep-CAM pro výrobu farmaceutického prostredku
AT410172B (de) 2000-03-21 2003-02-25 Igeneon Gmbh Verfahren zur herstellung einer vakzineformulierung
AT502293B1 (de) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie Immunogener, monoklonaler antikörper
AT500647A1 (de) * 2002-05-21 2006-02-15 Igeneon Krebs Immuntherapie Verwendung eines impfstoffes
AT500650B1 (de) * 2003-04-17 2009-11-15 Altropus Gmbh Immunogener rekombinanter antikörper
AT500651B9 (de) * 2003-05-27 2010-04-15 Altropus Gmbh Aktiv immunisierender antikörper
AU2004321433B2 (en) 2004-07-14 2011-07-21 Greenovation Biotech Gmbh N-glycosylated antibody
EP1618890B1 (en) * 2004-07-20 2010-10-06 Altropus Gmbh Use of antibodies in a very low dose for the vaccination against cancer
KR101205064B1 (ko) * 2005-04-26 2012-11-27 에자이 알앤드디 매니지먼트 가부시키가이샤 암 면역요법을 위한 조성물과 방법
EP1762575A1 (en) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
AT504231A1 (de) 2006-10-03 2008-04-15 Hans Dr Loibner Prädiktive parameter
BRPI0821165B8 (pt) 2007-12-07 2021-05-25 Nutricia Nv uso de uma composição
JP5764071B2 (ja) 2009-02-24 2015-08-12 エスバテック − ア ノバルティスカンパニー エルエルシー 細胞表面抗原のイムノバインダーを同定するための方法
US8887373B2 (en) 2012-02-24 2014-11-18 Covidien Lp Vessel sealing instrument with reduced thermal spread and method of manufacture therefor
US20140276968A1 (en) * 2013-03-14 2014-09-18 Ethicon, Inc. Applicator systems for surgical fasteners
US10196458B2 (en) * 2013-07-26 2019-02-05 The Regents Of The University Of California Anti-immunoglobulin E antibodies and methods of using thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5798100A (en) * 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
WO1997005597A1 (en) * 1995-07-31 1997-02-13 Litton Systems Canada Limited Flat panel pixel array incorporating photoconductive switches
EP0857176A1 (en) * 1995-10-25 1998-08-12 Centocor B.V. HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE
US6235280B1 (en) * 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US6274143B1 (en) * 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
DE69942742D1 (de) * 1998-06-15 2010-10-21 Quest Pharmatech Inc Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
CZ302801B6 (cs) * 1999-01-13 2011-11-16 Igeneon Krebs-Immuntherapie Forschungs Und Entwicklungs-Ag Použití protilátky namírené proti antigenu bunecné membrány Ep-CAM pro výrobu farmaceutického prostredku
US6632431B2 (en) * 2000-05-16 2003-10-14 New York University Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same

Also Published As

Publication number Publication date
ES2236375T3 (es) 2005-07-16
PT1140168E (pt) 2002-11-29
HUP0200527A2 (en) 2002-06-29
US20070224202A1 (en) 2007-09-27
PT1230932E (pt) 2005-04-29
NZ512722A (en) 2003-07-25
SI1230932T1 (en) 2005-06-30
US20120003232A1 (en) 2012-01-05
TR200102034T2 (tr) 2001-11-21
CZ20012581A3 (cs) 2002-01-16
SK9642001A3 (en) 2002-03-05
MXPA01007148A (es) 2002-03-27
ATE219687T1 (de) 2002-07-15
ATE286745T1 (de) 2005-01-15
IL144265A (en) 2006-08-20
WO2000041722A1 (de) 2000-07-20
SK286627B6 (sk) 2009-02-05
PL201533B1 (pl) 2009-04-30
US8444974B2 (en) 2013-05-21
CA2360382A1 (en) 2000-07-20
EP1140168A1 (de) 2001-10-10
EP1140168B1 (de) 2002-06-26
EE200100366A (et) 2002-10-15
CA2360382C (en) 2011-05-24
AU2796400A (en) 2000-08-01
JP2002534481A (ja) 2002-10-15
AU768515B2 (en) 2003-12-18
HU226150B1 (en) 2008-05-28
KR100771752B1 (ko) 2007-10-30
CZ302801B6 (cs) 2011-11-16
HK1044487A1 (en) 2002-10-25
ES2177509T3 (es) 2002-12-16
IL144265A0 (en) 2002-05-23
DK1230932T3 (da) 2005-04-25
PL364747A1 (en) 2004-12-13
NO20013093L (no) 2001-09-10
JP4774551B2 (ja) 2011-09-14
HRP20010526A2 (en) 2002-08-31
US20100233178A1 (en) 2010-09-16
ID30223A (id) 2001-11-15
CN1344167A (zh) 2002-04-10
EP1230932A2 (de) 2002-08-14
IS5998A (is) 2001-07-10
EP1230932A3 (de) 2003-11-26
NO329917B1 (no) 2011-01-24
HK1044487B (zh) 2005-09-16
EE05474B1 (et) 2011-10-17
DE50000243D1 (de) 2002-08-01
US7691372B2 (en) 2010-04-06
KR20010101446A (ko) 2001-11-14
CN1188169C (zh) 2005-02-09
DE50009240D1 (de) 2005-02-17
SI1140168T1 (en) 2002-10-31
DK1140168T3 (da) 2002-09-30
EP1230932B1 (de) 2005-01-12

Similar Documents

Publication Publication Date Title
NO20013093L (no) Anvendelse av antistoffer for vaksinering mot kreft
TR200001253T2 (tr) Tümöre özel antijenler
ATE402192T1 (de) Anti-ccr4 antikörper und fragmente davon
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
DE60202877D1 (de) Gezieltes antikörper-verfahren
CY1110783T1 (el) Μονοκλωνικα αντισωματα κατα αυξητικου παραγοντα ηπατοκυτταρων
CY1106400T1 (el) Συνθεση και μεθοδος ανοσοθepαπειας με καρκινικο αντιγονο
ATE529130T1 (de) Trockenformulierung für transkutane immunisierung
CY1113247T1 (el) Νουκλεϊνικα οξεα με τιτλο 273ρ4β7 και η χρηση τους στην ανιχνευση καρκινου
BRPI0412245A (pt) anticorpos de rg1 e usos destes
HUP9904620A2 (hu) Tisztított spermiumfelületi antigén,annak megfelelő monoklonális ellenanyag és alkalmazási területeik
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
ATE193974T1 (de) Chlamydia impfstoffen
ID22942A (id) Penggunaan antibodi burung
ATE483473T1 (de) Verwendung von antikörpern in einer sehr geringen dosis zur impfung gegen krebs
CY1114835T1 (el) Πληρη ανθρωπινα αντισωματα εναντι ανθρωπινου 4-1ββ (cd137)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees